DK0689599T3 - Kimære selectiner ved udveksling af domæner og anvendelser deraf - Google Patents

Kimære selectiner ved udveksling af domæner og anvendelser deraf

Info

Publication number
DK0689599T3
DK0689599T3 DK94907889T DK94907889T DK0689599T3 DK 0689599 T3 DK0689599 T3 DK 0689599T3 DK 94907889 T DK94907889 T DK 94907889T DK 94907889 T DK94907889 T DK 94907889T DK 0689599 T3 DK0689599 T3 DK 0689599T3
Authority
DK
Denmark
Prior art keywords
polypeptides
domains
chimeric
lectin
peptides
Prior art date
Application number
DK94907889T
Other languages
English (en)
Inventor
Thomas F Tedder
Geoffrey S Kansas
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Application granted granted Critical
Publication of DK0689599T3 publication Critical patent/DK0689599T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
DK94907889T 1993-01-25 1994-01-25 Kimære selectiner ved udveksling af domæner og anvendelser deraf DK0689599T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US845993A 1993-01-25 1993-01-25
PCT/US1994/000909 WO1994017193A2 (en) 1993-01-25 1994-01-25 Chimeric l- and p-selectin by exchange of domains - uses thereof

Publications (1)

Publication Number Publication Date
DK0689599T3 true DK0689599T3 (da) 1999-08-16

Family

ID=21731721

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94907889T DK0689599T3 (da) 1993-01-25 1994-01-25 Kimære selectiner ved udveksling af domæner og anvendelser deraf

Country Status (13)

Country Link
US (2) US5808025A (da)
EP (1) EP0689599B1 (da)
JP (1) JPH08506017A (da)
AT (1) ATE174344T1 (da)
AU (1) AU694933B2 (da)
CA (1) CA2153802A1 (da)
DE (1) DE69415154T2 (da)
DK (1) DK0689599T3 (da)
ES (1) ES2126742T3 (da)
GR (1) GR3029640T3 (da)
NZ (1) NZ261991A (da)
SG (1) SG48892A1 (da)
WO (1) WO1994017193A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648458A (en) * 1992-05-06 1997-07-15 Affymax Technologies N.V. Peptides and compounds that bind to ELAM-1
US5643873A (en) * 1992-05-06 1997-07-01 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
US5728802A (en) * 1992-05-06 1998-03-17 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1)
US20020040008A1 (en) * 1995-01-24 2002-04-04 Wagner Denisa D. Method for treating and preventing atherosclerosis
US20040116333A1 (en) * 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
US7744888B2 (en) 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
US7169376B2 (en) * 2004-06-10 2007-01-30 Chevron U.S.A. Inc. Method for making hydrogen using a gold containing water-gas shift catalyst
UY28886A1 (es) 2004-05-10 2005-12-30 Boehringer Ingelheim Int Anticuerpos que consisten en polipéptidos y derivados conprendiendo tres secuencias conteniendo respectivamente los siguientes números de seq. id: 1-3 y 4-6; 7-9 y 10-12 y 13-15 ó 16-18
MXPA06012987A (es) * 2004-05-11 2007-06-12 Abgenomics Corp Epitopos inductores de muerte de celulas t.
US20130209449A9 (en) 2011-06-13 2013-08-15 Abgenomics Cooperatief U.A. Anti-psgl-1 antibodies and uses thereof
CN121108302A (zh) * 2025-09-22 2025-12-12 渼达(广州)生物科技有限公司 一种重组人Fc和P-选择素的重组蛋白、检测产品及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783330A (en) * 1984-11-15 1988-11-08 New England Medical Center Hospitals, Inc. Monoclonal antibodies to activated platelets
US5081034A (en) * 1988-11-14 1992-01-14 Brigham & Women's Hospital Cloned genes which encode elam-1
US5098833A (en) * 1989-02-23 1992-03-24 Genentech, Inc. DNA sequence encoding a functional domain of a lymphocyte homing receptor
US5216131A (en) * 1989-02-23 1993-06-01 Genentech, Inc. Lymphocyte homing receptors
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US5026537A (en) * 1989-04-06 1991-06-25 Centocor, Inc. Methods for imaging atherosclerotic plaque
WO1991007993A1 (en) * 1989-11-30 1991-06-13 Mathew Vadas Anti-inflammatory and anti-adhesive factors
US5709859A (en) * 1991-01-24 1998-01-20 Bristol-Myers Squibb Company Mixed specificity fusion proteins
WO1992020712A1 (en) * 1991-05-15 1992-11-26 Dana-Farber Cancer Institute, Inc. Leukocyte-associated cell surface protein

Also Published As

Publication number Publication date
ES2126742T3 (es) 1999-04-01
SG48892A1 (en) 1998-05-18
NZ261991A (en) 1998-04-27
ATE174344T1 (de) 1998-12-15
CA2153802A1 (en) 1994-08-04
DE69415154T2 (de) 1999-07-29
EP0689599B1 (en) 1998-12-09
WO1994017193A2 (en) 1994-08-04
AU6128494A (en) 1994-08-15
DE69415154D1 (de) 1999-01-21
HK1011382A1 (en) 1999-07-09
GR3029640T3 (en) 1999-06-30
AU694933B2 (en) 1998-08-06
JPH08506017A (ja) 1996-07-02
EP0689599A1 (en) 1996-01-03
US5834425A (en) 1998-11-10
WO1994017193A3 (en) 1994-11-10
US5808025A (en) 1998-09-15

Similar Documents

Publication Publication Date Title
BR0212256A (pt) Proteìnas de fusão de transferrina modificadas
ES2126742T3 (es) Selectinas quimericas obtenidas mediante intercambio de dominios - sus usos.
PT842273E (pt) Ligando de receptor vegf-c
ES2188935T3 (es) Polipeptido de fusion para influir sobre interacciones entre proteinas.
WO2004020405A3 (en) Modified transferrin fusion proteins
UA89017C2 (uk) ЛЮДСЬКЕ АНТИТІЛО, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ЛЮДСЬКИМ TNFSF13b
NO20000086D0 (no) Chimerisk interleukin-6 opploeselig reseptor/ligandprotein, analoger derav og anvendelse av dette
HUP9904052A3 (en) Monoclonal antibodies againts the extracellular domain of human vegf-receptor protein (kdr)
DK0724456T3 (da) CD40-Antistoffer
DK0888385T3 (da) GDNF receptor og anvendelser deraf
DK297184D0 (da) Immunotoxin-konjugater til selektiv eliminering af cellepopulationer
WO1999026966A3 (en) Nuclear receptor ligands and ligand binding domains
DK0712931T4 (da) Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma
SE8400865D0 (sv) Platinaforening samt forfarande for dess framstellning
IL100731A (en) Mixed specificity fusion protein and pharmaceutical composition containing it
IT8448736A0 (it) Recettori monoclonali, indotti da polipeptidi, per leganti proteinici
DK0914325T3 (da) Modulatorer af funktionen af FAS receptorer og andre proteiner
DK1017715T3 (da) Kimært polypeptid der omfatter fragment B af shiga-toksin og peptider af terapeutisk interesse
NZ509536A (en) Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
DK556689A (da) Antistof-konjugater, fremgangsmaade til fremstilling heraf og farmaceutiske midler indeholdende disse
DK258789A (da) Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet
DK407987D0 (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
ATE542138T1 (de) Her-2-bindungsantagonisten
FR2797689B1 (fr) Utilisation de composes synthetiques pour des immunodosages
DE60330680D1 (de) Transferrin-fusionsproteinbibliotheken